Go Pro

Qorvo (QRVO) Financials

Qorvo logo
$98.16 -0.08 (-0.08%)
As of 02:31 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Qorvo

Annual Income Statements for Qorvo

This table shows Qorvo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/2/2016 4/1/2017 3/31/2018 3/30/2019 3/28/2020 4/3/2021 4/2/2022 4/1/2023 3/30/2024 3/29/2025 3/28/2026
Net Income / (Loss) Attributable to Common Shareholders
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Consolidated Net Income / (Loss)
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Net Income / (Loss) Continuing Operations
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Total Pre-Tax Income
-2.86 27 17 92 395 807 1,181 125 74 66 398
Total Operating Income
12 88 70 216 423 907 1,226 183 92 96 411
Total Gross Profit
1,050 1,136 1,147 1,195 1,322 1,884 2,286 1,297 1,488 1,536 1,688
Total Revenue
2,611 3,033 2,974 3,090 3,239 4,015 4,646 3,569 3,770 3,719 3,679
Operating Revenue
2,611 3,033 2,974 3,090 3,239 4,015 4,646 3,569 3,770 3,719 3,679
Total Cost of Revenue
1,561 1,897 1,827 1,895 1,917 2,132 2,360 2,272 2,281 2,183 1,990
Operating Cost of Revenue
1,561 1,897 1,827 1,895 1,917 2,132 2,360 2,272 2,281 2,183 1,990
Total Operating Expenses
1,038 1,047 1,077 979 899 977 1,060 1,114 1,397 1,440 1,277
Selling, General & Admin Expense
534 546 632 528 414 407 388 241 276 268 253
Marketing Expense
- - - - - - - 211 217 232 215
Research & Development Expense
449 471 445 450 484 570 624 650 682 748 726
Impairment Charge
- - - - - - 48 12 221 193 82
Total Other Income / (Expense), net
-15 -61 -53 -125 -28 -99 -45 -59 -18 -30 -13
Interest Expense
23 59 60 44 60 75 63 68 69 78 73
Other Income / (Expense), net
6.42 -3.09 -0.61 -81 32 -24 18 9.92 51 49 60
Income Tax Expense
26 44 57 -41 61 74 148 21 144 10 59
Basic Earnings per Share
($0.20) ($0.13) ($0.32) $1.07 $2.86 $6.43 $9.38 $1.01 ($0.72) $0.59 $3.66
Weighted Average Basic Shares Outstanding
141.94M 127.12M 126.95M 124.53M 117.01M 114.03M 110.20M 102.21M 97.56M 94.59M 92.59M
Diluted Earnings per Share
($0.20) ($0.13) ($0.32) $1.05 $2.80 $6.32 $9.26 $1.00 ($0.72) $0.58 $3.62
Weighted Average Diluted Shares Outstanding
141.94M 127.12M 126.95M 127.36M 119.29M 116.02M 111.55M 103.02M 97.56M 95.45M 93.55M
Weighted Average Basic & Diluted Shares Outstanding
144.20M 127.40M 125.90M 124.40M 114.73M 112.59M 106.03M 98.74M 95.63M 93.03M 88.01M

Quarterly Income Statements for Qorvo

This table shows Qorvo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026 6/27/2026
Net Income / (Loss) Attributable to Common Shareholders
-127 2.74 0.41 -17 41 31 26 120 164 30 86
Consolidated Net Income / (Loss)
-127 2.74 0.41 -17 41 31 26 120 164 30 86
Net Income / (Loss) Continuing Operations
-127 2.74 0.41 -17 41 31 26 120 164 30 86
Total Pre-Tax Income
-44 30 -0.72 2.50 49 15 32 155 190 22 101
Total Operating Income
-42 30 4.61 9.68 53 28 30 158 192 32 97
Total Gross Profit
388 382 332 445 391 367 332 497 464 395 401
Total Revenue
1,074 941 887 1,047 916 869 819 1,059 993 808 785
Operating Revenue
1,074 941 887 1,047 916 869 819 1,059 993 808 785
Total Cost of Revenue
686 559 554 601 525 503 487 561 529 413 384
Operating Cost of Revenue
686 559 554 601 525 503 487 561 529 413 384
Total Operating Expenses
429 352 328 436 338 338 302 339 272 364 304
Selling, General & Admin Expense
92 -49 80 61 103 -170 66 81 45 61 83
Marketing Expense
- - 60 60 57 - 57 60 49 50 49
Research & Development Expense
164 180 188 201 179 180 179 198 178 170 172
Total Other Income / (Expense), net
-2.22 -0.46 -5.33 -7.17 -4.13 -13 1.60 -2.59 -2.34 -9.82 3.76
Interest Expense
18 17 17 23 19 20 19 18 18 18 16
Other Income / (Expense), net
15 17 12 15 15 6.99 20 16 16 8.02 20
Income Tax Expense
83 27 -1.14 20 7.63 -16 6.09 35 26 -8.04 15
Basic Earnings per Share
($1.31) $0.03 $0.00 ($0.18) $0.44 $0.33 $0.28 $1.29 $1.77 $0.32 $0.97
Weighted Average Basic Shares Outstanding
97.15M 97.56M 95.47M 94.89M 94.34M 94.59M 92.92M 92.80M 92.59M 92.59M 88.04M
Diluted Earnings per Share
($1.31) $0.04 $0.00 ($0.18) $0.43 $0.33 $0.27 $1.28 $1.75 $0.32 $0.96
Weighted Average Diluted Shares Outstanding
97.15M 97.56M 96.51M 94.89M 95.03M 95.45M 93.77M 93.79M 93.57M 93.55M 89.36M
Weighted Average Basic & Diluted Shares Outstanding
96.55M 95.63M 94.86M 94.53M 93.40M 93.03M 92.65M 92.40M 92.71M 88.01M 88.22M

Annual Cash Flow Statements for Qorvo

This table details how cash moves in and out of Qorvo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/2/2016 4/1/2017 3/31/2018 3/30/2019 3/28/2020 4/3/2021 4/2/2022 4/1/2023 3/30/2024 3/29/2025 3/28/2026
Net Change in Cash & Equivalents
126 120 381 -215 4.23 683 -426 -164 240 -26 198
Net Cash From Operating Activities
688 777 853 810 946 1,302 1,049 843 833 622 809
Net Cash From Continuing Operating Activities
688 777 853 810 946 1,302 1,049 843 833 622 809
Net Income / (Loss) Continuing Operations
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Consolidated Net Income / (Loss)
-29 -17 -40 133 334 734 1,033 103 -70 56 339
Depreciation Expense
180 210 174 209 222 203 211 206 193 163 151
Amortization Expense
495 495 540 454 247 253 150 132 128 134 111
Non-Cash Adjustments To Reconcile Net Income
136 89 113 178 51 157 132 345 342 329 218
Changes in Operating Assets and Liabilities, net
-94 -0.01 64 -164 91 -44 -477 56 240 -59 -11
Net Cash From Investing Activities
-279 -490 -277 -248 -1,106 -219 -596 -153 -136 37 -44
Net Cash From Continuing Investing Activities
-279 -490 -277 -248 -1,106 -219 -596 -153 -136 37 -44
Purchase of Property, Plant & Equipment
-316 -553 -270 -221 -164 -187 -213 -159 -127 -138 -129
Acquisitions
0.00 -118 0.00 0.00 -946 -47 -389 -0.10 -83 -0.79 0.00
Sale of Property, Plant & Equipment
- - - - - - 0.90 1.85 50 7.06 52
Divestitures
- - - - - - - 0.00 20 173 21
Other Investing Activities, net
-13 -5.98 -7.57 -27 4.41 15 5.75 3.79 4.19 -5.23 12
Net Cash From Financing Activities
-283 -166 -197 -777 166 -402 -876 -853 -460 -684 -567
Net Cash From Continuing Financing Activities
-283 -166 -197 -777 166 -402 -876 -853 -460 -684 -567
Repayment of Debt
-189 0.00 -110 -1,060 -6.72 -1,098 -207 -0.69 -69 -463 -26
Repurchase of Common Equity
-1,300 -209 -220 -638 -515 -515 -1,152 -862 -400 -356 -533
Issuance of Common Equity
52 59 57 41 50 43 38 33 37 36 35
Other Financing Activities, net
-21 -16 -25 -25 -22 -39 -53 -23 -27 99 -44
Cash Interest Paid
2.16 71 70 56 49 81 59 66 55 76 73

Quarterly Cash Flow Statements for Qorvo

This table details how cash moves in and out of Qorvo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026 6/27/2026
Net Change in Cash & Equivalents
385 -43 33 14 -327 252 144 -62 215 -99 110
Net Cash From Operating Activities
493 202 81 128 214 199 183 84 265 276 139
Net Cash From Continuing Operating Activities
493 202 81 128 214 199 183 84 265 276 139
Net Income / (Loss) Continuing Operations
-127 2.74 0.41 -17 41 31 26 120 164 30 86
Consolidated Net Income / (Loss)
-127 2.74 0.41 -17 41 31 26 120 164 30 86
Depreciation Expense
48 46 41 40 41 40 39 39 37 36 35
Amortization Expense
31 36 35 36 32 30 28 28 28 27 15
Non-Cash Adjustments To Reconcile Net Income
195 31 42 135 28 130 42 40 27 109 34
Changes in Operating Assets and Liabilities, net
346 87 -38 -65 71 -33 47 -143 9.00 75 -31
Net Cash From Investing Activities
0.90 -113 -17 -35 -7.07 96 -33 -33 4.28 18 -23
Net Cash From Continuing Investing Activities
0.90 -113 -17 -35 -7.07 96 -33 -33 4.28 18 -23
Purchase of Property, Plant & Equipment
-26 -33 -38 -33 -38 -29 -38 -42 -28 -21 -24
Other Investing Activities, net
27 0.41 -35 -3.11 30 2.74 4.21 9.12 11 -12 1.30
Net Cash From Financing Activities
-114 -132 -30 -80 -532 -43 -6.94 -113 -54 -392 -6.47
Net Cash From Continuing Financing Activities
-114 -132 -30 -80 -532 -43 -6.94 -113 -54 -392 -6.47
Repayment of Debt
-18 -41 -34 -3.36 -421 -4.97 -5.17 -4.50 -9.13 -6.93 -4.79
Repurchase of Common Equity
-100 -100 -125 -81 -100 -50 -50 -65 -17 -400 0.00
Issuance of Common Equity
5.32 11 9.51 12 3.35 11 9.83 12 3.59 10 8.73
Other Financing Activities, net
-0.85 -0.79 120 -6.51 -14 0.19 38 -55 -31 4.50 -10
Effect of Exchange Rate Changes
4.84 - - 0.75 -2.35 0.34 1.62 -0.19 -0.29 - -0.25

Annual Balance Sheets for Qorvo

This table presents Qorvo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/2/2016 4/1/2017 3/31/2018 3/30/2019 3/28/2020 4/3/2021 4/2/2022 4/1/2023 3/30/2024 3/29/2025 3/28/2026
Total Assets
6,597 6,522 6,382 5,808 6,561 7,221 7,509 6,692 6,555 5,933 5,826
Total Current Assets
1,509 1,462 1,844 1,685 1,691 2,484 2,450 2,030 2,446 2,167 2,306
Cash & Equivalents
426 545 926 711 715 1,398 973 809 1,029 1,021 1,219
Accounts Receivable
364 423 391 400 382 485 601 331 427 398 399
Inventories, net
428 430 472 512 517 508 756 797 711 641 554
Prepaid Expenses
64 36 24 26 38 42 50 47 41 33 37
Other Current Assets
41 26 31 36 38 52 71 47 79 75 98
Plant, Property, & Equipment, net
1,047 1,392 1,374 1,367 1,259 1,266 1,254 1,150 871 802 710
Total Noncurrent Assets
4,041 3,669 3,164 2,757 3,611 3,472 3,806 3,512 3,238 2,964 2,809
Long-Term Investments
26 35 64 98 23 35 31 20 23 23 16
Goodwill
2,136 2,174 2,174 2,174 2,614 2,643 2,776 2,761 2,535 2,390 2,353
Intangible Assets
1,813 1,401 860 408 809 611 675 538 509 273 122
Other Noncurrent Operating Assets
66 59 66 77 165 182 324 193 170 277 318
Total Liabilities & Shareholders' Equity
6,597 6,522 6,382 5,808 6,561 7,221 7,509 6,692 6,555 5,933 5,826
Total Liabilities
1,597 1,626 1,606 1,448 2,268 2,592 2,956 2,789 2,998 2,541 2,481
Total Current Liabilities
374 419 441 436 539 682 675 556 1,230 783 713
Accounts Payable
205 216 213 233 247 314 328 211 253 261 243
Accrued Expenses
138 171 167 161 218 255 240 222 337 288 248
Other Current Liabilities
31 32 61 42 67 113 107 122 113 235 222
Total Noncurrent Liabilities
1,223 1,207 1,165 1,013 1,729 1,910 2,281 2,233 1,768 1,758 1,769
Long-Term Debt
988 989 983 921 1,567 1,743 2,047 2,048 1,549 1,549 1,549
Other Noncurrent Operating Liabilities
83 86 118 92 162 168 234 185 219 208 219
Total Equity & Noncontrolling Interests
5,000 4,897 4,776 4,360 4,293 4,629 4,553 3,903 3,556 3,392 3,344
Total Preferred & Common Equity
5,000 4,897 4,776 4,360 4,293 4,629 4,553 3,903 3,556 3,392 3,344
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
5,000 4,897 4,776 4,360 4,293 4,629 4,553 3,903 3,556 3,392 3,344
Common Stock
5,443 5,357 5,237 4,687 4,290 4,245 4,036 3,821 3,651 3,431 3,301
Retained Earnings
-440 -456 -459 -321 0.00 355 512 84 -90 -34 39
Accumulated Other Comprehensive Income / (Loss)
-3.13 -4.31 -2.75 -6.62 2.29 30 5.23 -3.18 -5.10 -5.01 4.06

Quarterly Balance Sheets for Qorvo

This table presents Qorvo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 6/28/2025 9/27/2025 12/27/2025 6/27/2026
Total Assets
6,687 6,719 6,699 6,555 6,447 6,503 5,963 5,998 6,096 6,164 5,939
Total Current Assets
2,088 2,263 2,428 2,446 2,378 2,532 2,097 2,246 2,377 2,483 2,437
Cash & Equivalents
744 707 1,072 1,029 1,082 1,096 769 1,165 1,103 1,319 1,329
Accounts Receivable
327 621 515 427 440 594 439 343 560 520 396
Inventories, net
917 840 727 711 727 694 656 638 605 530 592
Prepaid Expenses
49 49 40 41 30 38 38 31 34 35 39
Other Current Assets
49 46 75 79 99 110 78 69 74 79 81
Plant, Property, & Equipment, net
1,088 1,061 1,039 871 867 847 821 794 781 755 680
Total Noncurrent Assets
3,511 3,394 3,232 3,238 3,202 3,124 3,045 2,957 2,938 2,925 2,822
Long-Term Investments
27 26 25 23 26 25 26 22 17 19 15
Goodwill
2,761 2,708 2,540 2,535 2,533 2,438 2,437 2,390 2,390 2,390 2,353
Intangible Assets
507 473 500 509 474 446 332 252 224 197 106
Other Noncurrent Operating Assets
216 187 166 170 170 216 250 293 306 320 348
Total Liabilities & Shareholders' Equity
6,687 6,719 6,699 6,555 6,447 6,503 5,963 5,998 6,096 6,164 5,939
Total Liabilities
2,874 2,901 3,061 2,998 2,961 3,093 2,583 2,560 2,586 2,466 2,468
Total Current Liabilities
639 672 1,280 1,230 1,217 1,334 808 798 805 676 688
Accounts Payable
294 275 283 253 304 322 283 280 285 241 253
Accrued Expenses
264 304 327 337 300 354 268 252 287 225 214
Other Current Liabilities
80 93 190 113 200 246 227 266 232 210 221
Total Noncurrent Liabilities
2,235 2,229 1,781 1,768 1,745 1,759 1,775 1,762 1,781 1,790 1,780
Long-Term Debt
2,048 2,049 1,550 1,549 1,549 1,549 1,549 1,549 1,549 1,549 1,549
Other Noncurrent Operating Liabilities
187 181 230 219 195 210 226 213 232 241 231
Total Equity & Noncontrolling Interests
3,812 3,817 3,638 3,556 3,486 3,410 3,380 3,437 3,510 3,698 3,472
Total Preferred & Common Equity
3,812 3,817 3,638 3,556 3,486 3,410 3,380 3,437 3,510 3,698 3,472
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,812 3,817 3,638 3,556 3,486 3,410 3,380 3,437 3,510 3,698 3,472
Common Stock
3,816 3,796 3,731 3,651 3,581 3,516 3,456 3,439 3,431 3,465 3,345
Retained Earnings
0.00 35 -92 -90 -89 -107 -65 -8.39 73 227 125
Accumulated Other Comprehensive Income / (Loss)
-4.04 -14 0.10 -5.10 -6.03 1.15 -10 6.36 5.48 6.37 2.66

Annual Metrics And Ratios for Qorvo

This table displays calculated financial ratios and metrics derived from Qorvo's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/2/2016 4/1/2017 3/31/2018 3/30/2019 3/28/2020 4/3/2021 4/2/2022 4/1/2023 3/30/2024 3/29/2025 3/28/2026
DEI Shares Outstanding
- - - - - - - - - - 92,705,679.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 92,705,679.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 3.66
Growth Metrics
- - - - - - - - - - -
Revenue Growth
52.59% 16.16% -1.95% 3.93% 4.82% 23.96% 15.70% -23.17% 5.61% -1.34% -1.09%
EBITDA Growth
103.93% 13.87% -0.72% 1.91% 15.72% 44.81% 19.96% -66.87% -12.82% -4.89% 66.37%
EBIT Growth
-84.96% 362.16% -18.00% 94.84% 235.52% 93.77% 41.00% -84.48% -26.04% 1.00% 226.85%
NOPAT Growth
-95.78% -737.41% -209.27% 290.09% 14.08% 130.03% 30.22% -85.87% -157.83% 191.96% 334.37%
Net Income Growth
-114.69% 42.60% -143.31% 430.43% 151.14% 119.43% 40.86% -90.02% -168.17% 179.09% 509.53%
EPS Growth
-109.48% 35.00% -146.15% 428.13% 166.67% 125.71% 46.52% -89.20% -172.00% 180.56% 524.14%
Operating Cash Flow Growth
125.09% 12.92% 9.74% -4.94% 16.69% 37.67% -19.40% -19.63% -1.19% -25.32% 29.96%
Free Cash Flow Firm Growth
105.78% -103.26% 4,105.23% 64.85% -148.98% 438.88% -59.11% 50.97% -2.05% -1.42% -2.60%
Invested Capital Growth
-4.90% -0.83% -10.10% -6.23% 14.70% -3.72% 13.32% -8.48% -13.69% -11.85% -6.13%
Revenue Q/Q Growth
-1.02% 1.17% 0.76% 0.50% 3.41% 7.64% 2.05% -13.00% 8.91% -1.89% -1.64%
EBITDA Q/Q Growth
19.10% -0.99% -2.10% 5.94% 2.34% 15.32% -2.04% -45.95% 95.15% -4.87% -0.51%
EBIT Q/Q Growth
119.20% -29.27% -8.38% 267.74% 5.40% 31.32% -2.91% -69.82% 266.51% -7.44% 0.93%
NOPAT Q/Q Growth
112.08% 71.75% -278.13% 271.74% 2.47% 38.81% -6.37% -70.32% 1.59% 146.26% -1.31%
Net Income Q/Q Growth
-1,668.52% 82.87% -243.27% 125.23% -3.22% 51.18% -7.72% -77.27% 66.75% 106.10% -0.48%
EPS Q/Q Growth
58.33% 82.19% -252.38% 123.40% -2.78% 51.92% -6.18% -76.58% 65.22% 100.00% -0.28%
Operating Cash Flow Q/Q Growth
3.17% 12.67% 1.41% -8.12% 2.94% 16.93% -5.16% -24.96% 19.66% -0.51% 10.54%
Free Cash Flow Firm Q/Q Growth
0.00% 88.85% -9.24% 13.41% -337.19% 166.13% -6.82% -32.58% 0.85% 8.44% 19.73%
Invested Capital Q/Q Growth
-1.45% -0.31% -4.73% -1.75% 7.43% -0.97% -1.60% -2.80% -3.30% -3.71% -6.44%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
40.20% 37.44% 38.57% 38.68% 40.81% 46.91% 49.21% 36.34% 39.49% 41.29% 45.89%
EBITDA Margin
26.56% 26.04% 26.36% 25.85% 28.54% 33.34% 34.57% 14.90% 12.30% 11.86% 19.95%
Operating Margin
0.46% 2.90% 2.36% 7.00% 13.07% 22.58% 26.39% 5.13% 2.43% 2.57% 11.18%
EBIT Margin
0.70% 2.80% 2.34% 4.39% 14.06% 21.98% 26.79% 5.41% 3.79% 3.88% 12.82%
Profit (Net Income) Margin
-1.10% -0.55% -1.35% 4.31% 10.32% 18.27% 22.24% 2.89% -1.87% 1.50% 9.22%
Tax Burden Percent
1,007.86% -60.64% -234.98% 145.03% 84.62% 90.86% 87.49% 82.77% -95.60% 84.39% 85.11%
Interest Burden Percent
-15.57% 32.13% 24.61% 67.62% 86.74% 91.48% 94.91% 64.54% 51.51% 45.69% 84.49%
Effective Tax Rate
0.00% 160.64% 334.98% -45.03% 15.38% 9.14% 12.51% 17.23% 195.60% 15.61% 14.89%
Return on Invested Capital (ROIC)
0.15% -1.00% -3.28% 6.79% 7.46% 16.36% 20.36% 2.83% -1.84% 1.94% 9.27%
ROIC Less NNEP Spread (ROIC-NNEP)
37.50% 8.72% 58.89% -335.39% 2.44% 0.63% 14.54% -1.45% -0.17% -1.71% 6.53%
Return on Net Nonoperating Assets (RNNOA)
-0.67% 0.67% 2.45% -3.88% 0.27% 0.08% 2.14% -0.39% -0.05% -0.34% 0.79%
Return on Equity (ROE)
-0.52% -0.33% -0.83% 2.91% 7.73% 16.44% 22.51% 2.44% -1.89% 1.60% 10.06%
Cash Return on Invested Capital (CROIC)
5.17% -0.17% 7.36% 13.23% -6.24% 20.15% 7.87% 11.68% 12.86% 14.54% 15.59%
Operating Return on Assets (OROA)
0.27% 1.30% 1.08% 2.23% 7.37% 12.81% 16.90% 2.72% 2.16% 2.31% 8.02%
Return on Assets (ROA)
-0.43% -0.25% -0.62% 2.18% 5.41% 10.65% 14.03% 1.45% -1.06% 0.89% 5.77%
Return on Common Equity (ROCE)
-0.52% -0.33% -0.83% 2.91% 7.73% 16.44% 22.51% 2.44% -1.89% 1.60% 10.06%
Return on Equity Simple (ROE_SIMPLE)
-0.58% -0.34% -0.84% 3.05% 7.79% 15.85% 22.70% 2.64% -1.98% 1.64% 0.00%
Net Operating Profit after Tax (NOPAT)
8.38 -53 -165 314 358 824 1,073 152 -88 81 350
NOPAT Margin
0.32% -1.76% -5.55% 10.16% 11.06% 20.52% 23.09% 4.25% -2.33% 2.17% 9.52%
Net Nonoperating Expense Percent (NNEP)
-37.35% -9.73% -62.17% 342.18% 5.02% 15.74% 5.82% 4.28% -1.66% 3.65% 2.74%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 1.63% 7.16%
Cost of Revenue to Revenue
59.80% 62.56% 61.43% 61.33% 59.19% 53.09% 50.79% 63.67% 60.51% 58.71% 54.11%
SG&A Expenses to Revenue
20.46% 17.99% 21.24% 17.09% 12.79% 10.12% 8.36% 12.65% 13.08% 7.20% 6.87%
R&D to Revenue
17.19% 15.53% 14.97% 14.58% 14.96% 14.21% 13.42% 18.21% 18.10% 20.11% 19.74%
Operating Expenses to Revenue
39.74% 34.54% 36.21% 31.67% 27.74% 24.33% 22.82% 31.20% 37.06% 38.72% 34.71%
Earnings before Interest and Taxes (EBIT)
18 85 70 136 455 883 1,244 193 143 144 471
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
693 790 784 799 924 1,339 1,606 532 464 441 734
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.39 1.77 1.87 2.02 2.17 4.72 2.89 2.60 3.12 1.97 2.14
Price to Tangible Book Value (P/TBV)
6.63 6.56 5.12 4.95 10.74 15.88 11.95 16.79 21.64 9.16 8.25
Price to Revenue (P/Rev)
2.67 2.86 3.00 2.85 2.88 5.44 2.84 2.84 2.94 1.80 1.95
Price to Earnings (P/E)
0.00 0.00 0.00 66.16 27.92 29.78 12.75 98.36 0.00 120.07 21.15
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 1.51% 3.58% 3.36% 7.84% 1.02% 0.00% 0.83% 4.73%
Enterprise Value to Invested Capital (EV/IC)
1.37 1.71 1.87 1.99 1.98 4.49 2.54 2.22 2.72 1.84 2.05
Enterprise Value to Revenue (EV/Rev)
2.80 2.99 2.99 2.89 3.14 5.52 3.06 3.18 3.19 1.93 2.03
Enterprise Value to EBITDA (EV/EBITDA)
10.55 11.50 11.36 11.17 11.00 16.55 8.85 21.37 25.92 16.28 10.20
Enterprise Value to EBIT (EV/EBIT)
397.97 106.83 127.81 65.71 22.33 25.11 11.43 58.86 84.19 49.80 15.88
Enterprise Value to NOPAT (EV/NOPAT)
873.41 0.00 0.00 28.41 28.40 26.90 13.26 74.97 0.00 89.09 21.37
Enterprise Value to Operating Cash Flow (EV/OCF)
10.64 11.69 10.45 11.01 10.76 17.02 13.55 13.48 14.43 11.54 9.26
Enterprise Value to Free Cash Flow (EV/FCFF)
25.79 0.00 24.02 14.60 0.00 21.84 34.28 18.15 19.60 11.88 12.71
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.20 0.20 0.21 0.21 0.37 0.38 0.45 0.52 0.56 0.46 0.46
Long-Term Debt to Equity
0.20 0.20 0.21 0.21 0.37 0.38 0.45 0.52 0.44 0.46 0.46
Financial Leverage
-0.02 0.08 0.04 0.01 0.11 0.13 0.15 0.27 0.28 0.20 0.12
Leverage Ratio
1.21 1.33 1.33 1.33 1.43 1.54 1.60 1.68 1.78 1.80 1.75
Compound Leverage Factor
-0.19 0.43 0.33 0.90 1.24 1.41 1.52 1.08 0.91 0.82 1.47
Debt to Total Capital
16.50% 16.81% 17.07% 17.44% 26.83% 27.35% 31.02% 34.42% 35.86% 31.35% 31.66%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.12% 0.00% 0.00% 0.01% 7.91% 0.00% 0.00%
Long-Term Debt to Total Capital
16.50% 16.81% 17.07% 17.44% 26.71% 27.35% 31.02% 34.41% 27.94% 31.35% 31.66%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
83.50% 83.19% 82.93% 82.56% 73.17% 72.65% 68.98% 65.58% 64.14% 68.65% 68.34%
Debt to EBITDA
1.42 1.25 1.25 1.15 1.70 1.30 1.27 3.85 4.29 3.51 2.11
Net Debt to EBITDA
0.50 0.52 -0.01 0.14 0.91 0.23 0.65 2.29 2.02 1.14 0.43
Long-Term Debt to EBITDA
1.42 1.25 1.25 1.15 1.70 1.30 1.27 3.85 3.34 3.51 2.11
Debt to NOPAT
117.95 -18.52 -5.95 2.93 4.40 2.12 1.91 13.51 -22.68 19.22 4.42
Net Debt to NOPAT
41.71 -7.64 0.04 0.36 2.34 0.38 0.97 8.04 -10.67 6.26 0.90
Long-Term Debt to NOPAT
117.95 -18.52 -5.95 2.93 4.38 2.12 1.91 13.51 -17.67 19.22 4.42
Altman Z-Score
3.14 3.80 3.99 4.44 3.40 6.39 4.22 3.09 3.07 2.56 2.97
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.04 3.49 4.18 3.87 3.14 3.64 3.63 3.65 1.99 2.77 3.24
Quick Ratio
2.61 2.31 2.98 2.55 2.04 2.76 2.33 2.05 1.18 1.81 2.27
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
284 -9.26 371 611 -299 1,014 415 626 613 605 589
Operating Cash Flow to CapEx
217.96% 140.55% 315.94% 366.79% 576.25% 696.33% 493.60% 536.73% 1,072.56% 476.63% 1,045.30%
Free Cash Flow to Firm to Interest Expense
12.17 -0.16 6.23 13.90 -4.96 13.49 6.55 9.15 8.86 7.72 8.05
Operating Cash Flow to Interest Expense
29.50 13.19 14.32 18.43 15.66 17.31 16.57 12.32 12.03 7.94 11.06
Operating Cash Flow Less CapEx to Interest Expense
15.97 3.81 9.79 13.41 12.94 14.83 13.21 10.02 10.91 6.28 10.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.39 0.46 0.46 0.51 0.52 0.58 0.63 0.50 0.57 0.60 0.63
Accounts Receivable Turnover
7.02 7.71 7.31 7.82 8.28 9.26 8.56 7.66 9.94 9.01 9.24
Inventory Turnover
4.03 4.42 4.05 3.85 3.73 4.16 3.73 2.93 3.03 3.23 3.33
Fixed Asset Turnover
2.71 2.49 2.15 2.26 2.47 3.18 3.69 2.97 3.73 4.45 4.86
Accounts Payable Turnover
8.05 9.00 8.51 8.49 7.98 7.60 7.35 8.44 9.84 8.50 7.91
Days Sales Outstanding (DSO)
51.97 47.36 49.96 46.70 44.08 39.40 42.65 47.66 36.72 40.49 39.51
Days Inventory Outstanding (DIO)
90.53 82.54 90.20 94.77 97.94 87.75 97.73 124.67 120.58 112.97 109.54
Days Payable Outstanding (DPO)
45.34 40.56 42.91 43.00 45.71 48.01 49.64 43.26 37.10 42.93 46.17
Cash Conversion Cycle (CCC)
97.16 89.34 97.25 98.47 96.31 79.14 90.74 129.07 120.21 110.53 102.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,349 5,305 4,769 4,472 5,129 4,939 5,597 5,122 4,421 3,897 3,658
Invested Capital Turnover
0.48 0.57 0.59 0.67 0.67 0.80 0.88 0.67 0.79 0.89 0.97
Increase / (Decrease) in Invested Capital
-275 -44 -536 -297 657 -191 658 -475 -701 -524 -239
Enterprise Value (EV)
7,317 9,078 8,905 8,920 10,171 22,158 14,219 11,365 12,022 7,182 7,485
Market Capitalization
6,968 8,670 8,911 8,808 9,335 21,848 13,176 10,146 11,087 6,678 7,171
Book Value per Share
$36.47 $38.72 $37.75 $35.51 $37.11 $40.87 $41.99 $39.07 $36.84 $36.32 $36.07
Tangible Book Value per Share
$7.67 $10.46 $13.77 $14.48 $7.52 $12.14 $10.17 $6.05 $5.31 $7.81 $9.38
Total Capital
5,988 5,886 5,759 5,281 5,867 6,372 6,600 5,951 5,544 4,942 4,893
Total Debt
988 989 983 921 1,574 1,743 2,047 2,048 1,988 1,549 1,549
Total Long-Term Debt
988 989 983 921 1,567 1,743 2,047 2,048 1,549 1,549 1,549
Net Debt
349 408 -6.51 112 837 309 1,043 1,219 936 505 314
Capital Expenditures (CapEx)
316 553 270 221 164 187 213 157 78 131 77
Debt-free, Cash-free Net Working Capital (DFCFNWC)
523 497 476 538 443 404 802 666 625 363 375
Debt-free Net Working Capital (DFNWC)
1,135 1,043 1,403 1,249 1,158 1,802 1,775 1,474 1,655 1,384 1,594
Net Working Capital (NWC)
1,135 1,043 1,403 1,249 1,151 1,802 1,775 1,474 1,216 1,384 1,594
Net Nonoperating Expense (NNE)
37 -37 -125 181 24 90 39 48 -17 25 11
Net Nonoperating Obligations (NNO)
349 408 -6.51 112 837 309 1,043 1,219 865 505 314
Total Depreciation and Amortization (D&A)
675 705 714 663 469 456 361 339 321 297 262
Debt-free, Cash-free Net Working Capital to Revenue
20.02% 16.40% 16.02% 17.42% 13.69% 10.07% 17.27% 18.65% 16.59% 9.76% 10.18%
Debt-free Net Working Capital to Revenue
43.49% 34.39% 47.17% 40.43% 35.76% 44.88% 38.20% 41.31% 43.90% 37.22% 43.32%
Net Working Capital to Revenue
43.49% 34.39% 47.17% 40.42% 35.55% 44.88% 38.20% 41.30% 32.26% 37.22% 43.32%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.20) $0.00 ($0.32) $1.07 $2.86 $6.43 $9.38 $1.01 ($0.72) $0.59 $3.66
Adjusted Weighted Average Basic Shares Outstanding
141.94M 0.00 126.95M 124.53M 117.01M 114.03M 110.20M 102.21M 97.56M 94.59M 92.59M
Adjusted Diluted Earnings per Share
($0.20) $0.00 ($0.32) $1.05 $2.80 $6.32 $9.26 $1.00 ($0.72) $0.58 $3.62
Adjusted Weighted Average Diluted Shares Outstanding
141.94M 0.00 126.95M 127.36M 119.29M 116.02M 111.55M 103.02M 97.56M 95.45M 93.55M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
127.53M 0.00 126.49M 119.15M 114.73M 112.59M 106.03M 98.74M 95.63M 93.03M 88.01M
Normalized Net Operating Profit after Tax (NOPAT)
8.38 62 49 152 358 824 1,115 162 219 243 420
Normalized NOPAT Margin
0.32% 2.03% 1.65% 4.90% 11.06% 20.52% 23.99% 4.54% 5.81% 6.54% 11.43%
Pre Tax Income Margin
-0.11% 0.90% 0.58% 2.97% 12.20% 20.11% 25.42% 3.49% 1.95% 1.77% 10.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.79 1.44 1.17 3.09 7.54 11.74 19.65 2.82 2.06 1.84 6.45
NOPAT to Interest Expense
0.36 -0.91 -2.77 7.14 5.93 10.95 16.94 2.21 -1.27 1.03 4.79
EBIT Less CapEx to Interest Expense
-12.75 -7.94 -3.36 -1.94 4.82 9.25 16.29 0.53 0.94 0.17 5.39
NOPAT Less CapEx to Interest Expense
-13.18 -10.29 -7.30 2.12 3.21 8.47 13.58 -0.08 -2.39 -0.64 3.73
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-4,506.88% -1,264.39% -545.84% 479.30% 154.08% 70.21% 111.51% 835.42% -568.89% 640.72% 157.10%

Quarterly Metrics And Ratios for Qorvo

This table displays calculated financial ratios and metrics derived from Qorvo's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026 6/27/2026
DEI Shares Outstanding
- - - - - - - - - 92,705,679.00 88,013,673.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 92,705,679.00 88,013,673.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.32 0.97
Growth Metrics
- - - - - - - - - - -
Revenue Growth
44.48% 48.73% 36.17% -5.16% -14.67% -7.60% -7.66% 1.15% 8.36% -7.04% -4.15%
EBITDA Growth
-46.53% 231.83% 98.58% -57.11% 168.51% -17.57% 27.47% 137.49% 93.34% -3.54% 41.20%
EBIT Growth
-283.40% 125.74% 147.56% -83.98% 357.73% -24.76% 208.30% 591.63% 207.66% 12.28% 130.58%
NOPAT Growth
-576.22% 102.10% 109.57% -163.71% 253.81% 1,993.08% 653.75% 280.43% 271.08% -25.71% 239.87%
Net Income Growth
-696.80% 101.98% 100.95% -117.89% 132.51% 1,046.80% 6,082.13% 785.99% 297.52% -5.21% 235.24%
EPS Growth
-718.75% 103.05% 100.00% -118.18% 132.82% 725.00% 0.00% 811.11% 306.98% -3.03% 255.56%
Operating Cash Flow Growth
107.68% 209.19% 80.63% 37.46% -56.57% -1.56% 125.62% -34.30% 23.98% 38.70% -23.75%
Free Cash Flow Firm Growth
57.53% 105.59% 122.79% 103.38% -14.75% -17.28% -25.05% -46.82% -46.78% -51.57% -63.79%
Invested Capital Growth
-13.23% -13.69% -14.73% -17.20% -11.48% -11.85% -12.45% -7.34% -3.39% -6.13% -3.21%
Revenue Q/Q Growth
-2.69% -12.37% -5.77% 18.03% -12.44% -5.11% -5.83% 29.28% -6.19% -18.60% -2.91%
EBITDA Q/Q Growth
-77.68% 144.20% -28.04% 9.36% 39.73% -25.03% 11.27% 103.75% 13.76% -62.60% 62.88%
EBIT Q/Q Growth
-116.73% 278.54% -65.02% 53.30% 169.16% -47.88% 43.35% 243.91% 19.73% -80.98% 194.40%
NOPAT Q/Q Growth
-127.51% 109.55% 16.06% -2,190.21% 166.41% 29.92% -58.20% 400.36% 36.58% -73.99% 91.21%
Net Income Q/Q Growth
-230.24% 102.15% -84.86% -4,311.35% 336.71% -24.00% -18.40% 367.31% 37.17% -81.88% 188.60%
EPS Q/Q Growth
-232.32% 103.05% -100.00% 0.00% 338.89% -23.26% -18.18% 374.07% 36.72% -81.71% 200.00%
Operating Cash Flow Q/Q Growth
430.00% -58.95% -59.93% 57.67% 67.46% -6.96% -8.15% -54.09% 216.03% 4.08% -49.51%
Free Cash Flow Firm Q/Q Growth
66.63% 5.33% 6.99% 8.30% -30.16% 2.21% -3.06% -23.16% -30.09% -6.99% -27.51%
Invested Capital Q/Q Growth
-10.93% -3.30% -1.85% -2.05% -4.78% -3.71% -2.51% 3.66% -0.72% -6.44% 0.53%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
36.12% 40.58% 37.48% 42.55% 42.72% 42.16% 40.52% 46.96% 46.75% 48.87% 51.09%
EBITDA Margin
4.90% 13.66% 10.43% 9.67% 15.43% 12.19% 14.40% 22.70% 27.53% 12.65% 21.22%
Operating Margin
-3.87% 3.19% 0.52% 0.92% 5.79% 3.25% 3.67% 14.90% 19.35% 3.90% 12.33%
EBIT Margin
-2.44% 4.97% 1.85% 2.40% 7.37% 4.05% 6.16% 16.40% 20.93% 4.89% 14.83%
Profit (Net Income) Margin
-11.82% 0.29% 0.05% -1.67% 4.50% 3.61% 3.13% 11.30% 16.52% 3.68% 10.93%
Tax Burden Percent
289.87% 9.27% -57.26% -696.56% 84.41% 206.04% 80.78% 77.12% 86.44% 137.07% 85.35%
Interest Burden Percent
167.08% 63.07% -4.42% 9.97% 72.38% 43.24% 62.78% 89.35% 91.33% 54.87% 86.38%
Effective Tax Rate
0.00% 90.73% 0.00% 796.56% 15.59% -106.04% 19.22% 22.88% 13.56% -37.07% 14.65%
Return on Invested Capital (ROIC)
-1.91% 0.23% 0.31% -5.42% 4.30% 5.98% 2.66% 10.28% 15.72% 5.20% 10.26%
ROIC Less NNEP Spread (ROIC-NNEP)
-11.51% 0.23% 0.05% -0.79% 3.86% 2.07% 2.88% 9.96% 15.26% 1.91% 11.39%
Return on Net Nonoperating Assets (RNNOA)
-3.01% 0.06% 0.01% -0.23% 0.88% 0.41% 0.50% 1.83% 1.89% 0.23% 0.94%
Return on Equity (ROE)
-4.91% 0.30% 0.32% -5.65% 5.18% 6.39% 3.17% 12.10% 17.62% 5.44% 11.20%
Cash Return on Invested Capital (CROIC)
12.36% 12.86% 15.26% 18.86% 12.94% 14.54% 15.72% 13.33% 12.36% 15.59% 14.19%
Operating Return on Assets (OROA)
-1.23% 2.83% 1.13% 1.43% 4.41% 2.41% 3.62% 9.54% 12.91% 3.06% 9.06%
Return on Assets (ROA)
-5.94% 0.17% 0.03% -1.00% 2.70% 2.15% 1.83% 6.57% 10.19% 2.30% 6.68%
Return on Common Equity (ROCE)
-4.91% 0.30% 0.32% -5.65% 5.18% 6.39% 3.17% 12.10% 17.62% 5.44% 11.20%
Return on Equity Simple (ROE_SIMPLE)
-5.81% 0.00% -0.76% -4.14% 0.80% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-29 2.78 3.22 -67 45 58 24 122 166 43 83
NOPAT Margin
-2.71% 0.30% 0.36% -6.44% 4.88% 6.69% 2.97% 11.49% 16.73% 5.34% 10.52%
Net Nonoperating Expense Percent (NNEP)
9.60% 0.00% 0.26% -4.63% 0.44% 3.91% -0.21% 0.31% 0.46% 3.29% -1.13%
Return On Investment Capital (ROIC_SIMPLE)
-0.51% - - - 0.91% 1.18% 0.49% 2.40% 3.17% 0.88% 1.65%
Cost of Revenue to Revenue
63.88% 59.42% 62.52% 57.45% 57.28% 57.84% 59.48% 53.04% 53.25% 51.13% 48.91%
SG&A Expenses to Revenue
8.54% -5.25% 15.80% 13.20% 17.38% -19.51% 8.01% 7.68% 4.49% 7.57% 10.57%
R&D to Revenue
15.30% 19.12% 21.16% 19.21% 19.55% 20.69% 21.89% 18.75% 17.93% 21.08% 21.97%
Operating Expenses to Revenue
39.99% 37.39% 36.96% 41.63% 36.93% 38.91% 36.85% 32.06% 27.40% 44.97% 38.76%
Earnings before Interest and Taxes (EBIT)
-26 47 16 25 68 35 50 174 208 40 116
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
53 129 93 101 141 106 118 240 273 102 167
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.01 3.12 3.18 2.88 2.00 1.97 2.27 2.46 2.15 2.14 2.38
Price to Tangible Book Value (P/TBV)
18.33 21.64 23.16 18.66 11.05 9.16 9.81 9.62 7.16 8.25 8.16
Price to Revenue (P/Rev)
3.17 2.94 2.77 2.49 1.78 1.80 2.14 2.35 2.13 1.95 2.27
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 250.18 120.07 96.54 39.57 23.36 21.15 20.70
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.40% 0.83% 1.04% 2.53% 4.28% 4.73% 4.83%
Enterprise Value to Invested Capital (EV/IC)
2.60 2.72 2.75 2.51 1.85 1.84 2.15 2.30 2.09 2.05 2.30
Enterprise Value to Revenue (EV/Rev)
3.44 3.19 2.98 2.70 1.98 1.93 2.24 2.47 2.18 2.03 2.32
Enterprise Value to EBITDA (EV/EBITDA)
50.06 25.92 23.45 28.45 16.19 16.28 17.50 14.94 11.08 10.20 10.82
Enterprise Value to EBIT (EV/EBIT)
0.00 84.19 61.73 171.91 48.17 49.80 45.77 27.68 17.49 15.88 15.76
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 5,665.32 229.26 89.09 82.07 38.74 23.02 21.37 20.73
Enterprise Value to Operating Cash Flow (EV/OCF)
17.08 14.43 13.75 11.80 12.00 11.54 11.27 13.30 11.17 9.26 11.07
Enterprise Value to Free Cash Flow (EV/FCFF)
19.56 19.60 16.61 12.06 13.46 11.88 12.76 16.58 16.61 12.71 15.97
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.56 0.56 0.56 0.58 0.46 0.46 0.45 0.44 0.42 0.46 0.45
Long-Term Debt to Equity
0.43 0.44 0.44 0.45 0.46 0.46 0.45 0.44 0.42 0.46 0.45
Financial Leverage
0.26 0.28 0.29 0.30 0.23 0.20 0.18 0.18 0.12 0.12 0.08
Leverage Ratio
1.77 1.78 1.80 1.83 1.80 1.80 1.80 1.82 1.71 1.75 1.73
Compound Leverage Factor
2.95 1.12 -0.08 0.18 1.31 0.78 1.13 1.63 1.56 0.96 1.49
Debt to Total Capital
35.82% 35.86% 36.00% 36.51% 31.43% 31.35% 31.07% 30.62% 29.52% 31.66% 30.85%
Short-Term Debt to Total Capital
8.47% 7.91% 7.56% 7.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
27.35% 27.94% 28.44% 28.84% 31.43% 31.35% 31.07% 30.62% 29.52% 31.66% 30.85%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
64.18% 64.14% 64.00% 63.49% 68.57% 68.65% 68.93% 69.38% 70.48% 68.34% 69.15%
Debt to EBITDA
8.54 4.29 3.85 5.23 3.34 3.51 3.32 2.56 2.10 2.11 1.98
Net Debt to EBITDA
3.93 2.02 1.67 2.24 1.63 1.14 0.78 0.71 0.29 0.43 0.26
Long-Term Debt to EBITDA
6.52 3.34 3.04 4.13 3.34 3.51 3.32 2.56 2.10 2.11 1.98
Debt to NOPAT
-22.79 -22.68 -64.21 1,041.65 47.32 19.22 15.58 6.63 4.37 4.42 3.79
Net Debt to NOPAT
-10.48 -10.67 -27.93 446.19 23.04 6.26 3.64 1.83 0.60 0.90 0.50
Long-Term Debt to NOPAT
-17.40 -17.67 -50.73 822.75 47.32 19.22 15.58 6.63 4.37 4.42 3.79
Altman Z-Score
2.84 3.02 3.08 2.72 2.49 2.50 2.75 3.02 3.06 2.73 3.07
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.90 1.99 1.95 1.90 2.60 2.77 2.81 2.95 3.67 3.24 3.54
Quick Ratio
1.24 1.18 1.25 1.27 1.50 1.81 1.89 2.07 2.72 2.27 2.51
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
668 704 753 816 570 582 564 434 303 282 204
Operating Cash Flow to CapEx
1,874.82% 660.95% 212.74% 403.11% 580.80% 835.15% 487.29% 200.95% 931.50% 0.00% 577.75%
Free Cash Flow to Firm to Interest Expense
38.01 40.73 44.05 36.10 30.53 29.13 30.04 23.46 16.82 15.81 12.89
Operating Cash Flow to Interest Expense
28.04 11.71 4.74 5.66 11.48 9.97 9.74 4.54 14.73 15.49 8.80
Operating Cash Flow Less CapEx to Interest Expense
26.54 9.94 2.51 4.25 9.50 8.77 7.74 2.28 13.15 17.19 7.28
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.50 0.57 0.61 0.60 0.60 0.60 0.59 0.58 0.62 0.63 0.61
Accounts Receivable Turnover
7.58 9.94 10.44 6.50 7.95 9.01 9.32 6.35 7.80 9.24 9.86
Inventory Turnover
2.83 3.03 2.94 3.13 3.24 3.23 3.10 3.19 3.51 3.33 3.07
Fixed Asset Turnover
3.10 3.73 4.10 4.14 4.08 4.45 4.40 4.50 4.74 4.86 4.94
Accounts Payable Turnover
8.82 9.84 8.06 8.04 7.91 8.50 7.24 6.84 7.94 7.91 7.08
Days Sales Outstanding (DSO)
48.15 36.72 34.96 56.14 45.90 40.49 39.15 57.49 46.79 39.51 37.02
Days Inventory Outstanding (DIO)
129.06 120.58 124.32 116.64 112.69 112.97 117.69 114.25 104.09 109.54 118.99
Days Payable Outstanding (DPO)
41.40 37.10 45.26 45.39 46.15 42.93 50.41 53.33 45.96 46.17 51.58
Cash Conversion Cycle (CCC)
135.81 120.21 114.02 127.38 112.45 110.53 106.43 118.42 104.92 102.89 104.43
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,572 4,421 4,339 4,250 4,047 3,897 3,799 3,938 3,910 3,658 3,677
Invested Capital Turnover
0.70 0.79 0.85 0.84 0.88 0.89 0.90 0.89 0.94 0.97 0.97
Increase / (Decrease) in Invested Capital
-697 -701 -750 -883 -525 -524 -540 -312 -137 -239 -122
Enterprise Value (EV)
11,896 12,022 11,950 10,668 7,505 7,182 8,162 9,047 8,169 7,485 8,468
Market Capitalization
10,962 11,087 11,097 9,828 6,751 6,678 7,800 8,619 7,957 7,171 8,263
Book Value per Share
$37.38 $36.84 $36.46 $35.95 $35.76 $36.32 $36.95 $37.88 $40.03 $36.07 $39.45
Tangible Book Value per Share
$6.14 $5.31 $5.01 $5.55 $6.46 $7.81 $8.55 $9.67 $12.03 $9.38 $11.50
Total Capital
5,669 5,544 5,447 5,372 4,930 4,942 4,986 5,059 5,247 4,893 5,021
Total Debt
2,030 1,988 1,961 1,961 1,549 1,549 1,549 1,549 1,549 1,549 1,549
Total Long-Term Debt
1,550 1,549 1,549 1,549 1,549 1,549 1,549 1,549 1,549 1,549 1,549
Net Debt
934 936 853 840 754 505 362 428 212 314 205
Capital Expenditures (CapEx)
26 31 38 32 37 24 38 42 28 -30 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)
556 625 491 514 520 363 282 469 489 375 420
Debt-free Net Working Capital (DFNWC)
1,628 1,655 1,574 1,611 1,289 1,384 1,448 1,572 1,807 1,594 1,749
Net Working Capital (NWC)
1,148 1,216 1,162 1,199 1,289 1,384 1,448 1,572 1,807 1,594 1,749
Net Nonoperating Expense (NNE)
98 0.04 2.81 -50 3.49 27 -1.29 2.00 2.02 13 -3.21
Net Nonoperating Obligations (NNO)
934 865 853 840 667 505 362 428 212 314 205
Total Depreciation and Amortization (D&A)
79 82 76 76 74 71 67 67 66 63 50
Debt-free, Cash-free Net Working Capital to Revenue
16.06% 16.59% 12.26% 13.03% 13.71% 9.76% 7.74% 12.80% 13.07% 10.18% 11.53%
Debt-free Net Working Capital to Revenue
47.04% 43.90% 39.29% 40.80% 34.01% 37.22% 39.66% 42.92% 48.33% 43.32% 47.99%
Net Working Capital to Revenue
33.17% 32.26% 29.00% 30.36% 34.01% 37.22% 39.66% 42.92% 48.33% 43.32% 47.99%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.31) $0.03 $0.00 ($0.18) $0.44 $0.33 $0.28 $1.29 $1.77 $0.32 $0.97
Adjusted Weighted Average Basic Shares Outstanding
97.15M 97.56M 95.47M 94.89M 94.34M 94.59M 92.92M 92.80M 92.59M 92.59M 88.04M
Adjusted Diluted Earnings per Share
($1.31) $0.04 $0.00 ($0.18) $0.43 $0.33 $0.27 $1.28 $1.75 $0.32 $0.96
Adjusted Weighted Average Diluted Shares Outstanding
97.15M 97.56M 96.51M 94.89M 95.03M 95.45M 93.77M 93.79M 93.57M 93.55M 89.36M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
96.55M 95.63M 94.86M 94.53M 93.40M 93.03M 92.65M 92.40M 92.71M 88.01M 88.22M
Normalized Net Operating Profit after Tax (NOPAT)
92 21 3.22 74 45 20 24 122 166 22 83
Normalized NOPAT Margin
8.59% 2.23% 0.36% 7.10% 4.88% 2.27% 2.97% 11.49% 16.73% 2.73% 10.52%
Pre Tax Income Margin
-4.08% 3.14% -0.08% 0.24% 5.34% 1.75% 3.87% 14.65% 19.11% 2.68% 12.81%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-1.49 2.71 0.96 1.11 3.62 1.76 2.69 9.39 11.53 2.22 7.34
NOPAT to Interest Expense
-1.66 0.16 0.19 -2.98 2.40 2.91 1.29 6.58 9.21 2.42 5.21
EBIT Less CapEx to Interest Expense
-2.99 0.94 -1.27 -0.29 1.65 0.57 0.69 7.13 9.95 3.92 5.82
NOPAT Less CapEx to Interest Expense
-3.15 -1.61 -2.04 -4.39 0.42 1.72 -0.70 4.32 7.63 4.13 3.69
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-212.82% -568.89% -1,614.13% -287.75% 1,505.90% 640.72% 348.18% 121.67% 53.57% 157.10% 120.90%

Financials Breakdown Chart

Key Financial Trends

Qorvo’s latest results show a significant improvement in profitability compared with the weak results reported during fiscal 2025. In Q1 fiscal 2027, revenue was $784.8 million, down from $808.3 million in the prior quarter and below the $1.06 billion reported in Q2 fiscal 2026. However, gross profit increased to $401.0 million, producing a gross margin of approximately 51.1%. Operating income rose to $96.8 million, or roughly 12.3% of revenue, compared with $31.5 million in Q4 fiscal 2026.

Net income was $85.8 million, or $0.96 per diluted share, versus $29.7 million, or $0.32 per share, in the prior quarter. The improvement reflects stronger gross margins and lower operating expenses, particularly selling, general and administrative costs. Research and development spending remained elevated at $172.4 million, indicating that Qorvo continues to invest heavily in product development.

The balance sheet remains reasonably liquid. Qorvo ended the quarter with $1.33 billion in cash and equivalents and $2.44 billion in current assets against $688 million in current liabilities, implying a current ratio of approximately 3.5. Long-term debt was largely unchanged at $1.55 billion, leaving the company with modest net debt of approximately $220 million. Operating cash flow was $139.5 million, and capital expenditures of $24.1 million resulted in estimated free cash flow of approximately $115.4 million.

  • Profitability has recovered: Q1 fiscal 2027 operating income of $96.8 million and net income of $85.8 million were substantially higher than the $31.5 million and $29.7 million reported in Q4 fiscal 2026.
  • Gross margin improved: The latest gross margin was approximately 51.1%, up from 48.9% in Q4 fiscal 2026 and 46.8% in Q1 fiscal 2026, suggesting better product mix, pricing or manufacturing efficiency.
  • Cash generation remains positive: Qorvo produced $139.5 million of operating cash flow and approximately $115.4 million of free cash flow in the latest quarter despite a sequential decline in operating cash flow.
  • Liquidity is strong: Cash and equivalents of $1.33 billion and a current ratio near 3.5 provide a substantial cushion for operations, debt service and future investment.
  • Debt is stable and manageable: Long-term debt has remained near $1.55 billion across recent quarters, while Qorvo continues to make debt repayments without relying on significant new borrowing.
  • Share count has declined: Diluted weighted-average shares fell to 89.4 million in Q1 fiscal 2027 from 93.5 million in Q4 fiscal 2026, partly reflecting the company’s prior share-repurchase activity and supporting per-share earnings.
  • Revenue recovery is incomplete: Revenue has improved substantially from the fiscal 2025 downturn, but the latest $784.8 million was below the $993.0 million in Q3 fiscal 2026 and $1.06 billion in Q2 fiscal 2026.
  • Operating cash flow is volatile: Cash flow from operations was $139.5 million in the latest quarter, compared with $276.3 million in Q4 and $265.4 million in Q3. Changes in operating assets and liabilities reduced cash flow by $30.9 million.
  • Customer and end-market cyclicality remain a risk: Quarterly revenue has fluctuated widely, ranging from $651.2 million in Q1 fiscal 2024 to more than $1.1 billion in earlier periods, highlighting Qorvo’s exposure to changing semiconductor demand.
  • Asset concentration warrants monitoring: Goodwill of $2.35 billion and intangible assets of $106.3 million represented a large portion of total assets. Future operating weakness could increase the risk of impairment charges, which affected results in prior periods.

Overall, Qorvo’s financial statements point to a company emerging from a difficult operating period, with improving margins, positive free cash flow and strong liquidity. The main questions for investors are whether the margin recovery can continue and whether revenue can return to the levels seen earlier in fiscal 2026. Until revenue growth becomes more consistent, the stock’s fundamental outlook remains improved but still cyclical.

08/13/26 02:31 PM ETAI Generated. May Contain Errors.

Qorvo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Qorvo's fiscal year ends in March. Their fiscal year 2026 ended on March 28, 2026.

Qorvo's net income appears to be on an upward trend, with a most recent value of $338.99 million in 2026, falling from -$28.85 million in 2016. The previous period was $55.62 million in 2025. View Qorvo's forecast to see where analysts expect Qorvo to go next.

Qorvo's total operating income in 2026 was $411.42 million, based on the following breakdown:
  • Total Gross Profit: $1.69 billion
  • Total Operating Expenses: $1.28 billion

Over the last 10 years, Qorvo's total revenue changed from $2.61 billion in 2016 to $3.68 billion in 2026, a change of 40.9%.

Qorvo's total liabilities were at $2.48 billion at the end of 2026, a 2.3% decrease from 2025, and a 55.4% increase since 2016.

In the past 10 years, Qorvo's cash and equivalents has ranged from $425.88 million in 2016 to $1.40 billion in 2021, and is currently $1.22 billion as of their latest financial filing in 2026.

Over the last 10 years, Qorvo's book value per share changed from 36.47 in 2016 to 36.07 in 2026, a change of -1.1%.



Financial statements for NASDAQ:QRVO last updated on 7/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners